ProMIS Neurosciences, Inc. (PMN:NASDAQ) closed at $3.29 on November 13, 2026, down 5.46% on the day. The stock trades 88.0% below its 52-week high of $27.40 and 18.3% above its 52-week low of $2.78. Over the past year, it lost 63.4%. ProMIS Neurosciences, Inc. is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, PMN closed higher on 116 days (46%). Its best day was July 28, 2026 (+23.89%) and its worst was October 30, 2026 (-70.13%). The stock moved 10% or more in a single session 33 times. It opened at least 5% above the previous day's high 2 times.
ProMIS Neurosciences Inc is focused on the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases, including Alzheimer's disease, amyotrophic lateral sclerosis, and multiple system atrophy. The company also plans to investigate additional synucleionapathies, including Parkinson's disease, and dementia with Lewy bodies. It primarily operates in Canada.
Find more stocks like PMN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.